415 related articles for article (PubMed ID: 33879618)
1. DDX11 loss causes replication stress and pharmacologically exploitable DNA repair defects.
Jegadesan NK; Branzei D
Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33879618
[No Abstract] [Full Text] [Related]
2. Targeting DDX11 promotes PARP inhibitor sensitivity in hepatocellular carcinoma by attenuating BRCA2-RAD51 mediated homologous recombination.
Cao K; Wang R; Li L; Liao Y; Hu X; Li R; Liu X; Xiong XD; Wang Y; Liu X
Oncogene; 2024 Jan; 43(1):35-46. PubMed ID: 38007537
[TBL] [Abstract][Full Text] [Related]
3. Replication fork stability confers chemoresistance in BRCA-deficient cells.
Ray Chaudhuri A; Callen E; Ding X; Gogola E; Duarte AA; Lee JE; Wong N; Lafarga V; Calvo JA; Panzarino NJ; John S; Day A; Crespo AV; Shen B; Starnes LM; de Ruiter JR; Daniel JA; Konstantinopoulos PA; Cortez D; Cantor SB; Fernandez-Capetillo O; Ge K; Jonkers J; Rottenberg S; Sharan SK; Nussenzweig A
Nature; 2016 Jul; 535(7612):382-7. PubMed ID: 27443740
[TBL] [Abstract][Full Text] [Related]
4. Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA.
Xu Z; Li X; Li H; Nie C; Liu W; Li S; Liu Z; Wang W; Wang J
Oncogene; 2020 Nov; 39(47):7051-7062. PubMed ID: 32989256
[TBL] [Abstract][Full Text] [Related]
5. The iron-sulfur helicase DDX11 promotes the generation of single-stranded DNA for CHK1 activation.
Simon AK; Kummer S; Wild S; Lezaja A; Teloni F; Jozwiakowski SK; Altmeyer M; Gari K
Life Sci Alliance; 2020 Mar; 3(3):. PubMed ID: 32071282
[TBL] [Abstract][Full Text] [Related]
6. Warsaw Breakage Syndrome associated DDX11 helicase resolves G-quadruplex structures to support sister chromatid cohesion.
van Schie JJM; Faramarz A; Balk JA; Stewart GS; Cantelli E; Oostra AB; Rooimans MA; Parish JL; de Almeida Estéves C; Dumic K; Barisic I; Diderich KEM; van Slegtenhorst MA; Mahtab M; Pisani FM; Te Riele H; Ameziane N; Wolthuis RMF; de Lange J
Nat Commun; 2020 Aug; 11(1):4287. PubMed ID: 32855419
[TBL] [Abstract][Full Text] [Related]
7. Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors.
Joshi PM; Sutor SL; Huntoon CJ; Karnitz LM
J Biol Chem; 2014 Mar; 289(13):9247-53. PubMed ID: 24554720
[TBL] [Abstract][Full Text] [Related]
8. Tim/Timeless, a member of the replication fork protection complex, operates with the Warsaw breakage syndrome DNA helicase DDX11 in the same fork recovery pathway.
Calì F; Bharti SK; Di Perna R; Brosh RM; Pisani FM
Nucleic Acids Res; 2016 Jan; 44(2):705-17. PubMed ID: 26503245
[TBL] [Abstract][Full Text] [Related]
9. DNA helicases FANCM and DDX11 are determinants of PARP inhibitor sensitivity.
Stoepker C; Faramarz A; Rooimans MA; van Mil SE; Balk JA; Velleuer E; Ameziane N; Te Riele H; de Winter JP
DNA Repair (Amst); 2015 Feb; 26():54-64. PubMed ID: 25583207
[TBL] [Abstract][Full Text] [Related]
10. Warsaw breakage syndrome DDX11 helicase acts jointly with RAD17 in the repair of bulky lesions and replication through abasic sites.
Abe T; Ooka M; Kawasumi R; Miyata K; Takata M; Hirota K; Branzei D
Proc Natl Acad Sci U S A; 2018 Aug; 115(33):8412-8417. PubMed ID: 30061412
[TBL] [Abstract][Full Text] [Related]
11. Ganetespib overcomes resistance to PARP inhibitors in breast cancer by targeting core proteins in the DNA repair machinery.
Jiang J; Lu Y; Li Z; Li L; Niu D; Xu W; Liu J; Fu L; Zhou Z; Gu Y; Xia F
Invest New Drugs; 2017 Jun; 35(3):251-259. PubMed ID: 28111726
[TBL] [Abstract][Full Text] [Related]
12. [Poly(ADP-ribose) polymerase (PARP) inhibitors in BRCA1/2 cancer therapy].
Kluzek K; Białkowska A; Koczorowska A; Zdzienicka MZ
Postepy Hig Med Dosw (Online); 2012 Jun; 66():372-84. PubMed ID: 22706123
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic exploitation of tumor cell defects in homologous recombination.
Powell SN; Kachnic LA
Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
[TBL] [Abstract][Full Text] [Related]
14. [Abnormalities of DNA repair and gynecological cancers].
Auguste A; Leary A
Bull Cancer; 2017 Nov; 104(11):971-980. PubMed ID: 29054544
[TBL] [Abstract][Full Text] [Related]
15. [From poly(ADP-ribose) discovery to PARP inhibitors in cancer therapy].
Schreiber V; Illuzzi G; Héberlé E; Dantzer F
Bull Cancer; 2015 Oct; 102(10):863-73. PubMed ID: 26384693
[TBL] [Abstract][Full Text] [Related]
16. Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance.
Johnson N; Johnson SF; Yao W; Li YC; Choi YE; Bernhardy AJ; Wang Y; Capelletti M; Sarosiek KA; Moreau LA; Chowdhury D; Wickramanayake A; Harrell MI; Liu JF; D'Andrea AD; Miron A; Swisher EM; Shapiro GI
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17041-6. PubMed ID: 24085845
[TBL] [Abstract][Full Text] [Related]
17. The long non-coding RNA DDX11-AS1 facilitates cell progression and oxaliplatin resistance via regulating miR-326/IRS1 axis in gastric cancer.
Song W; Qian Y; Zhang MH; Wang H; Wen X; Yang XZ; Dai WJ
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3049-3061. PubMed ID: 32271422
[TBL] [Abstract][Full Text] [Related]
18. Chromodomain helicase DNA-binding protein 4 (CHD4) regulates homologous recombination DNA repair, and its deficiency sensitizes cells to poly(ADP-ribose) polymerase (PARP) inhibitor treatment.
Pan MR; Hsieh HJ; Dai H; Hung WC; Li K; Peng G; Lin SY
J Biol Chem; 2012 Feb; 287(9):6764-72. PubMed ID: 22219182
[TBL] [Abstract][Full Text] [Related]
19. 53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer.
Hurley RM; Wahner Hendrickson AE; Visscher DW; Ansell P; Harrell MI; Wagner JM; Negron V; Goergen KM; Maurer MJ; Oberg AL; Meng XW; Flatten KS; De Jonge MJA; Van Herpen CD; Gietema JA; Koornstra RHT; Jager A; den Hollander MW; Dudley M; Shepherd SP; Swisher EM; Kaufmann SH
Gynecol Oncol; 2019 Apr; 153(1):127-134. PubMed ID: 30686551
[TBL] [Abstract][Full Text] [Related]
20. The p53-binding protein 1-Tudor-interacting repair regulator complex participates in the DNA damage response.
Zhang A; Peng B; Huang P; Chen J; Gong Z
J Biol Chem; 2017 Apr; 292(16):6461-6467. PubMed ID: 28213517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]